Advanced search
Publication Cover
Acta Oncologica Volume 44, 2005 - Issue 8
Journal homepage
3,851
Views
74
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Number of patients potentially eligible for proton therapy

Bengt Glimelius Department of Oncology, Radiology and Clinical Immunology, and Department of Oncology and Pathology, Karolinska Institutet, Akademiska sjukhuset, Uppsala, Stockholm, SwedenCorrespondence[email protected]
,
Anders Ask Department of Oncology, University Hospital, Lund, Sweden
,
Göran Bjelkengren Department of Oncology, University Hospital, Malmö, Sweden
,
Thomas Björk-Eriksson Department of Oncology, University Hospital, Gothenburg, Sweden
,
Erik Blomquist Department of Oncology, Radiology and Clinical Immunology, and Department of Oncology and Pathology, Karolinska Institutet, Akademiska sjukhuset, Uppsala, Stockholm, Sweden
,
Bengt Johansson Department of Oncology, University Hospital, Örebro, Sweden
,
Mikael Karlsson Department of Radiation Physics, University Hospital, Umeå, Sweden
&
Björn Zackrisson Department of Oncology, University Hospital, Umeå, Sweden
 show all
Pages 836-849 | Received 23 Aug 2005, Published online: 08 Jul 2009

Citations (74)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (16)

Petter Brandal, Kjell Bergfeldt, Ninna Aggerholm-Pedersen, Gloria Bäckström, Irina Kerna, Michael Gubanski, Kirsten Björnlinger, Morten E. Evensen, Maire Kuddu, Erik Pettersson, Marianne Brydøy, Taran P. Hellebust, Einar Dale, Alexander Valdman, Lars Weber & Morten Høyer. (2020) A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients. Acta Oncologica 59:10, pages 1157-1163.
Read now
Kjell Bergfeldt, Håkan Nystrom, Petra Witt Nystrom & Morten Høyer. (2020) Is there a Nordic solution for the ‘proton-problem’?. Acta Oncologica 59:10, pages 1137-1138.
Read now
Petra Witt Nyström, Åse Bratland, Heikki Minn & Cai Grau. (2020) Ongoing and future clinical trials in particle therapy in the Nordic countries. Acta Oncologica 59:10, pages 1145-1150.
Read now
Leonhard Karsch, Elke Beyreuther, Wolfgang Enghardt, Malte Gotz, Umar Masood, Ulrich Schramm, Karl Zeil & Jörg Pawelke. (2017) Towards ion beam therapy based on laser plasma accelerators. Acta Oncologica 56:11, pages 1359-1366.
Read now
Francesco Dionisi, Stephen Avery, John N. Lukens, Xuanfeng Ding, John Kralik, Maura Kirk, Robert E. Roses, Maurizio Amichetti, James M. Metz & John P. Plastaras. (2014) Proton therapy in adjuvant treatment of gastric cancer: Planning comparison with advanced x-ray therapy and feasibility report. Acta Oncologica 53:10, pages 1312-1320.
Read now
Ludvig P. Muren, Carl Rossi, Eugen Hug, Andrew Lee & Bengt Glimelius. (2013) Establishing and expanding the indications for proton and particle therapy. Acta Oncologica 52:3, pages 459-462.
Read now
Håkan Nyström. (2010) The role of protons in modern and biologically-guided radiotherapy. Acta Oncologica 49:7, pages 1124-1131.
Read now
Rasa Ugenskiene, Kevin Prise, Melvyn Folkard, Janusz Lekki, Zbigniew Stachura, Monika Zazula & Jerzy Stachura. (2009) Dose response and kinetics of foci disappearance following exposure to high- and low-LET ionizing radiation. International Journal of Radiation Biology 85:10, pages 872-882.
Read now
Åsa Palm & Karl-Axel Johansson. (2007) A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors. Acta Oncologica 46:4, pages 462-473.
Read now
Bengt Glimelius. (2007) Acta Oncologica – achievements during 2006 and a look at the future. Acta Oncologica 46:1, pages 5-7.
Read now
Cai Grau, Morten Høyer, Jacob Lindegaard & Jens Overgaard. (2006) The emerging evidence for Stereotactic Body Radiotherapy. Acta Oncologica 45:7, pages 771-774.
Read now
Mikael Karlsson, Thomas Björk-Eriksson, Olof Mattsson, Sören Mattsson, Anders Montelius, Per Nilsson & Björn Zackrisson. (2006) “Distributed proton radiation therapy”-A new concept for advanced competence support. Acta Oncologica 45:8, pages 1094-1101.
Read now
Hiroshi Igaki, Koichi Tokuuye, Tohoru Takeda, Shinji Sugahara, Masaharu Hata, Takayuki Hashimoto, Nobuyoshi Fukumitsu, Jin Wu, Kayoko Ohnishi, Kiyoshi Ohara & Yasuyuki Akine. (2006) Sequential evaluation of hepatic functional reserve by 99mTechnetium-galactosyl human serum albumin scinitigraphy after proton beam therapy: a report of three cases and a review of the literatures. Acta Oncologica 45:8, pages 1102-1107.
Read now
Nobuyoshi Fukumitsu, Koichi Tokuuye, Shinji Sugahara, Takayuki Hashimoto, Masaharu Hata, Kiyoshi Ohara, Takeshi Shibahara, Akira Nakahara & Yasuyuki Akine. (2006) A patient surviving for eight years after proton and x-ray irradiation for advanced esophageal cancer. Acta Oncologica 45:8, pages 1132-1134.
Read now
Olav Dahl. (2005) Protons. A step forward or perhaps only more expensive radiation therapy?. Acta Oncologica 44:8, pages 798-800.
Read now
Michael Goitein & Gudrun Goitein. (2005) Swedish protons. Acta Oncologica 44:8, pages 793-797.
Read now

Articles from other publishers (58)

Kristaps Paļskis, Erika Korobeinikova, Dace Bogorada-Saukuma, Anna Maria Camarda, Rebecca Taylor, Elena Benedetto, Edgars Mamis, Maija Radziņa, Andrejs Ērglis, Diana Adliene, Manjit Dosanjh, Maurizio Vretenar & Toms Torims. (2024) “Particle therapy - future for the Baltic states?” – synthesis of the expert workshop report. Health and Technology.
Crossref
Anil Gupta, V. Subramani, Rishabh Kumar, Rafi Kareem, Bhaskar Vishwanathan & Daya Nand Sharma. (2024) Revolutionizing cancer treatment in India: Evaluating the unmet need, economics, and a roadmap for project implementation of particle therapy. Cancer.
Crossref
Florian Amstutz, Reinhardt Krcek, Barbara Bachtiary, Damien C. Weber, Antony J. Lomax, Jan Unkelbach & Ye Zhang. (2024) Treatment planning comparison for head and neck cancer between photon, proton, and combined proton–photon therapy – From a fixed beam line to an arc. Radiotherapy and Oncology 190, pages 109973.
Crossref
Jennifer Vogel & Christine Hill-Kayser. 2024. Palliative Radiation Oncology. Palliative Radiation Oncology 193 208 .
Susu Yan, Twalib A Ngoma, Wilfred Ngwa & Thomas R Bortfeld. (2023) Global democratisation of proton radiotherapy. The Lancet Oncology 24:6, pages e245-e254.
Crossref
K Sjövall, U Langegård, P Fransson, E Nevo-Ohlsson, I Kristensen, K Ahlberg & B Johansson. (2023) Evaluating patient reported outcomes and experiences in a novel proton beam clinic – challenges, activities, and outcomes of the ProtonCare project. BMC Cancer 23:1.
Crossref
Nathan Y. Yu, Todd A. DeWees, Molly M. Voss, William G. Breen, Jennifer S. Chiang, Julia X. Ding, Thomas B. Daniels, Dawn Owen, Kenneth R. Olivier, Yolanda I. Garces, Sean S. Park, Jann N. Sarkaria, Ping Yang, Panayiotis S. Savvides, Vinicius Ernani, Wei Liu, Steven E. Schild, Kenneth W. Merrell & Terence T. Sio. (2022) Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer. Clinical Lung Cancer 23:8, pages e526-e535.
Crossref
Gunita Mitera, Derek Tsang, Boyd McCurdy, Karen Goddard, Annie Ebacher, Tim Craig, Jonathan Greenland, Staci Kentish, Rashmi Koul, Natalie Logie, Mélanie Morneau, Andra Morrison, Larry Pan, Jason Pantarotto, Sophie Foxcroft, Jonathan Sussman, Robert Thompson, Scott Tyldesley, Philip Wright, Sarah Hicks, Erika Brown & Samir Patel. (2022) Pan-Canadian consensus recommendations for proton beam therapy access in Canada. Radiotherapy and Oncology 176, pages 228-233.
Crossref
Sofia Wagrell, Malena I. Havenvid, Åse Linné & Viktoria Sundquist. (2022) Building sustainable hospitals: A resource interaction perspective. Industrial Marketing Management 106, pages 420-431.
Crossref
Silvia Fabiano, Nathan Torelli, Dávid Papp & Jan Unkelbach. (2022) A novel stochastic optimization method for handling misalignments of proton and photon doses in combined treatments. Physics in Medicine & Biology 67:18, pages 185006.
Crossref
Dávid Papp & Jan Unkelbach. (2022) Technical note: Optimal allocation of limited proton therapy resources using model‐based patient selection. Medical Physics 49:8, pages 4980-4987.
Crossref
Neil G Burnet, Thomas Mee, Simona Gaito, Norman F Kirkby, Adam H Aitkenhead, Carmel N Anandadas, Marianne C Aznar, Lisa H Barraclough, Gerben Borst, Frances C Charlwood, Matthew Clarke, Rovel J Colaco, Adrian M Crellin, Noemie N Defourney, Christina J Hague, Margaret Harris, Nicholas T Henthorn, Kirsten I Hopkins, E Hwang, Sam P Ingram, Karen J Kirkby, Lip W Lee, David Lines, Zoe Lingard, Matthew Lowe, Ranald I Mackay, Catherine A McBain, Michael J Merchant, David J Noble, Shermaine Pan, James M Price, Ganesh Radhakrishna, David Reboredo-Gil, Ahmed Salem, Srijith Sashidharan, Peter Sitch, Ed Smith, Edward AK Smith, Michael J Taylor, David J Thomson, Nicola J Thorp, Tracy SA Underwood, John W Warmenhoven, James P Wylie & Gillian Whitfield. (2022) Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy. The British Journal of Radiology 95:1133.
Crossref
Srinivas Chilukuri, Pankaj Kumar Panda & Rakesh Jalali. (2022) Proton Therapy in LMICs: Is the Need Justified?. JCO Global Oncology:8.
Crossref
Mimoza M. Ristova, Vesna Gershan, Herwig Schopper, Ugo Amaldi & Manjit Dosanjh. (2021) Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST). Advances in Radiation Oncology 6:6, pages 100772.
Crossref
Daniel E. Hyer, Xuanfeng Ding & Yi Rong. (2021) Proton therapy needs further technological development to fulfill the promise of becoming a superior treatment modality (compared to photon therapy). Journal of Applied Clinical Medical Physics 22:11, pages 4-11.
Crossref
Pierre Loap, Viviana Vitolo, Amelia Barcellini, Ludovic De Marzi, Alfredo Mirandola, Maria Rosaria Fiore, Barbara Vischioni, Barbara Alicja Jereczek-Fossa, Nicolas Girard, Youlia Kirova & Ester Orlandi. (2021) Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice. Frontiers in Oncology 11.
Crossref
Nicolas Loizeau, Silvia Fabiano, Dávid Papp, Kristin Stützer, Annika Jakobi, Anna Bandurska-Luque, Esther G.C. Troost, Christian Richter & Jan Unkelbach. (2021) Optimal Allocation of Proton Therapy Slots in Combined Proton-Photon Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 111:1, pages 196-207.
Crossref
C Burbadge, E Kasanda, V Bildstein, G Dublin, B Olaizola, C Höhr & D Mücher. (2021) Proton therapy range verification method via delayed γ-ray spectroscopy of a molybdenum tumour marker. Physics in Medicine & Biology 66:2, pages 025005.
Crossref
Silvia Fabiano, Mark Bangert, Matthias Guckenberger & Jan Unkelbach. (2020) Accounting for Range Uncertainties in the Optimization of Combined Proton-Photon Treatments Via Stochastic Optimization. International Journal of Radiation Oncology*Biology*Physics 108:3, pages 792-801.
Crossref
Matthew S. Ning, Matthew B. Palmer, Aashish K. Shah, Laura C. Chambers, Laura B. Garlock, Benjamin B. Melson & Steven J. Frank. (2020) Three-Year Results of a Prospective Statewide Insurance Coverage Pilot for Proton Therapy: Stakeholder Collaboration Improves Patient Access to Care. JCO Oncology Practice 16:9, pages e966-e976.
Crossref
Fernando Hueso-Gonzalez & Thomas Bortfeld. (2020) Compact Method for Proton Range Verification Based on Coaxial Prompt Gamma-Ray Monitoring: A Theoretical Study. IEEE Transactions on Radiation and Plasma Medical Sciences 4:2, pages 170-183.
Crossref
Eleanor A Blakely, Bruce Faddegon, Christopher Tinkle, Charles Bloch, Michael Dominello, Robert J Griffin, Michael C Joiner & Jay Burmeister. (2019) Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility. Journal of Applied Clinical Medical Physics 20:11, pages 6-13.
Crossref
Jill S. Remick, Søren M. Bentzen, Charles B. SimoneIIII, Elizabeth Nichols, Mohan Suntharalingam & William F. Regine. (2019) Downstream Effect of a Proton Treatment Center on an Academic Medical Center. International Journal of Radiation Oncology*Biology*Physics 104:4, pages 756-764.
Crossref
Matthew S. Ning, Daniel R. Gomez, Aashish K. Shah, Charissa R. Kim, Matthew B. Palmer, Nikhil G. Thaker, David R. Grosshans, Zhongxing Liao, Bhavana V. Chapman, Eric D. Brooks, Chad Tang, David I. Rosenthal, Adam S. Garden, Steven J. Frank & G. Brandon Gunn. (2019) The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care. International Journal of Radiation Oncology*Biology*Physics 104:4, pages 724-733.
Crossref
Neige Journy, Daniel J. Indelicato, Diana R. Withrow, Tetsuo Akimoto, Claire Alapetite, Masayuki Araya, Andrew Chang, John Han-Chih Chang, Brian Chon, Michael E. Confer, Yusuke Demizu, Rémi Dendale, Jérôme Doyen, Ralph Ermoian, Kristin Gurtner, Christine Hill-Kayser, Hiromitsu Iwata, Joo-Young Kim, Young Kwok, Nadia N. Laack, Choonsik Lee, Do Hoon Lim, Lilia Loredo, Victor S. Mangona, David B. Mansur, Masao Murakami, Shigeyuki Murayama, Takashi Ogino, Barbora Ondrová, Rahul R. Parikh, Arnold C. Paulino, Stephanie Perkins, Naren R. Ramakrishna, Ronald Richter, Barbara Rombi, Satoshi Shibata, Shinichi Shimizu, Beate Timmermann, Tamara Vern-Gross, Chiachien J. Wang, Damien C. Weber, John Ben Wilkinson, Petra Witt Nyström, Torunn I. Yock, Ruth A. Kleinerman & Amy Berrington de Gonzalez. (2019) Patterns of proton therapy use in pediatric cancer management in 2016: An international survey. Radiotherapy and Oncology 132, pages 155-161.
Crossref
Yolande Lievens & Klaus Nagels. (2018) Economic data for particle therapy: Dealing with different needs in a heterogeneous landscape. Radiotherapy and Oncology 128:1, pages 19-25.
Crossref
Tamara Vern-Gross. (2018) Comprehensive care for the child or adolescent diagnosed with a childhood malignancy requiring palliative radiation therapy: A review. Applied Radiation Oncology, pages 7-17.
Crossref
Thomas R. Bortfeld & Jay S. Loeffler. (2017) Three ways to make proton therapy affordable. Nature 549:7673, pages 451-453.
Crossref
Paul B. Romesser, Oren Cahlon, Eli D. Scher, Eugen B. Hug, Kevin Sine, Carl DeSelm, Jana L. Fox, Dennis Mah, Madhur K. Garg, John Han-Chih Chang & Nancy Y. Lee. (2016) Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes. International Journal of Radiation Oncology*Biology*Physics 95:1, pages 386-395.
Crossref
Albert J. Schlocker & Benjamin W. Corn. (2016) Proton Beam Therapy in Small Nations: Financial Irrationality or Unique Collaborative Opportunity?. International Journal of Radiation Oncology*Biology*Physics 95:1, pages 21-24.
Crossref
Manjit Dosanjh, Manuela Cirilli & Sparsh Navin. (2015) Introduction to the EC’s Marie Curie Initial Training Network Project: The European Training Network in Digital Medical Imaging for Radiotherapy (ENTERVISION). Frontiers in Oncology 5.
Crossref
Bijan Arjomandy. (2015) Proton therapy advancement. Journal of Proton Therapy 1:1, pages 115.
Crossref
John Kerstiens & Peter A.S. Johnstone. (2014) Proton Therapy Expansion Under Current United States Reimbursement Models. International Journal of Radiation Oncology*Biology*Physics 89:2, pages 235-240.
Crossref
James Welsh, Arya Amini, Katherine Ciura, Ngoc Nguyen, Matt Palmer, Hendrick Soh, Pamela K. Allen, Michael Paolini, Zhongxing Liao, Jaques Bluett, Radhe Mohan, Daniel Gomez, James D. Cox, Ritsuko Komaki & Joe Y. Chang. (2013) Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer. Medical Dosimetry 38:4, pages 442-447.
Crossref
Tomas Dvorak, Markus M. Fitzek & David E. Wazer. (2013) Utilization of Proton Therapy. American Journal of Clinical Oncology 36:2, pages 192-196.
Crossref
Barry J. Allen, Eva Bezak & Loredana G. Marcu. (2013) Quo Vadis Radiotherapy? Technological Advances and the Rising Problems in Cancer Management. BioMed Research International 2013, pages 1-9.
Crossref
J L Habrand, E Baron, J Bourhis, J Datchary, A Mazal & K Meflah. (2012) Hadrontherapy - macrobenefit in cancer therapy?. Journal of Physics: Conference Series 373, pages 012018.
Crossref
Xiaojian Wu, Junxiao Zhang, Xiaosheng He, Chenliang Wang, Lei Lian, Huanliang Liu, Jianping Wang & Ping Lan. (2012) Postoperative Adjuvant Chemotherapy for Stage II Colorectal Cancer: A Systematic Review of 12 Randomized Controlled Trials. Journal of Gastrointestinal Surgery 16:3, pages 646-655.
Crossref
Erik Roelofs, Martijn Engelsman, Coen Rasch, Lucas Persoon, Sima Qamhiyeh, Dirk de Ruysscher, Frank Verhaegen, Madelon Pijls-Johannesma & Philippe Lambin. (2012) Results of a Multicentric In Silico Clinical Trial (ROCOCO): Comparing Radiotherapy with Photons and Protons for Non-small Cell Lung Cancer. Journal of Thoracic Oncology 7:1, pages 165-176.
Crossref
Michael H. Holzscheiter & Niels Bassler. 2012. Radiation Damage in Biomolecular Systems. Radiation Damage in Biomolecular Systems 491 506 .
Salvatore Devicienti, Lidia Strigari, Marco D'Andrea, Marcello Benassi, Vincenzo Dimiccoli & Maurizio Portaluri. (2010) Patient positioning in the proton radiotherapy era. Journal of Experimental & Clinical Cancer Research 29:1.
Crossref
A. Bouyon-Monteau, J.-L. Habrand, J. Datchary, C. Alapetite, S. Bolle, R. Dendale, L. Feuvret, S. Helfre, V. Calugaru, J.-M. Cosset & P. Bey. (2010) La protonthérapie : avenir de la radiothérapie ? Première partie : aspects cliniques. Cancer/Radiothérapie 14:8, pages 727-738.
Crossref
Tomas Dvorak & David E. Wazer. (2010) Evaluation of Potential Proton Therapy Utilization in a Market-Based Environment. Journal of the American College of Radiology 7:7, pages 522-528.
Crossref
Mark W. McDonald & Markus M. Fitzek. (2010) Proton Therapy. Current Problems in Cancer 34:4, pages 257-296.
Crossref
Dag Rune Olsen & Jens Overgaard. (2010) Leveraging clinical performance by technological excellence – The case of particle therapy. Radiotherapy and Oncology 95:1, pages 1-2.
Crossref
Michael Goitein. (2010) Trials and tribulations in charged particle radiotherapy. Radiotherapy and Oncology 95:1, pages 23-31.
Crossref
O. Kenneth Macdonald, Jon J. Kruse, Janelle M. Miller, Yolanda I. Garces, Paul D. Brown, Robert C. Miller & Robert L. Foote. (2009) Proton Beam Radiotherapy Versus Three-Dimensional Conformal Stereotactic Body Radiotherapy in Primary Peripheral, Early-Stage Non–Small-Cell Lung Carcinoma: A Comparative Dosimetric Analysis. International Journal of Radiation Oncology*Biology*Physics 75:3, pages 950-958.
Crossref
Michael L. Steinberg & Andre Konski. (2009) Proton Beam Therapy and the Convoluted Pathway to Incorporating Emerging Technology into Routine Medical Care in the United States. The Cancer Journal 15:4, pages 333-338.
Crossref
O. Kenneth Macdonald & Christopher M. Lee. (2009) Radiotherapy for Primary and Metastatic Spinal Tumors. Seminars in Spine Surgery 21:2, pages 121-128.
Crossref
Alfred R. Smith. (2009) Vision : Proton therapy. Medical Physics 36:2, pages 556-568.
Crossref
Madelon Pijls-Johannesma, Pascal Pommier & Yolande Lievens. (2008) Cost-effectiveness of particle therapy: Current evidence and future needs. Radiotherapy and Oncology 89:2, pages 127-134.
Crossref
Stefan Lorin, Erik Grusell, Nina Tilly, Joakim Medin, Peter Kimstrand & Bengt Glimelius. (2008) Reference dosimetry in a scanned pulsed proton beam using ionisation chambers and a Faraday cup. Physics in Medicine and Biology 53:13, pages 3519-3529.
Crossref
Michael Goitein & James D. Cox. (2008) In Reply. Journal of Clinical Oncology 26:15, pages 2593-2596.
Crossref
P. Hardy & P. Bridge. (2008) What are the potential benefits and limitations of particle therapy in the treatment of paediatric malignancies?. Journal of Radiotherapy in Practice 7:01, pages 9-18.
Crossref
Michael Goitein & James D. Cox. (2008) Should Randomized Clinical Trials Be Required for Proton Radiotherapy?. Journal of Clinical Oncology 26:2, pages 175-176.
Crossref
. (2008) REFERENCES. Journal of the ICRU 7:2, pages 189-210.
Crossref
Bengt Glimelius & Anders Montelius. (2007) Proton beam therapy – Do we need the randomised trials and can we do them?. Radiotherapy and Oncology 83:2, pages 105-109.
Crossref
Carlo Greco & Suzanne Wolden. (2007) Current status of radiotherapy with proton and light ion beams. Cancer 109:7, pages 1227-1238.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.